Atypical hyperplastic lesions of the female breast. A long-term follow-up study
- PMID: 2986821
- DOI: 10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a
Atypical hyperplastic lesions of the female breast. A long-term follow-up study
Abstract
A total of 10,542 breast biopsy specimens obtained between 1950 and 1968 were studied. Examples of atypical "ductal" (ADH) and atypical lobular hyperplasia (ALH), defined as having only some features of carcinoma in situ (CIS), were diagnosed in 3.6% of these specimens. In the same series, CIS was diagnosed in 1.7% of biopsy specimens excluding those with invasive cancer. The subsequent risk of invasive breast carcinoma after ALH or ADH was 4-5 times that of the general population. Follow-up was 90% successful and extended 17 years after biopsy. History of breast cancer in a mother, sister, or daughter doubled the risk of subsequent invasive carcinoma development (to 8 times for ALH and 10 times for ADH). The authors conclude that among the epithelial hyperplastic lesions of the human breast, a minority may be recognized by their resemblance to CIS which have a clinically significant elevation of subsequent breast cancer risk. This risk is one-half that of CIS.
Similar articles
-
Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?Radiology. 2004 Jun;231(3):813-9. doi: 10.1148/radiol.2313030874. Epub 2004 Apr 22. Radiology. 2004. PMID: 15105449
-
Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.Cancer Prev Res (Phila). 2014 Feb;7(2):211-7. doi: 10.1158/1940-6207.CAPR-13-0222. Epub 2014 Jan 30. Cancer Prev Res (Phila). 2014. PMID: 24480577 Free PMC article.
-
Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.Pathology. 2016 Jan;48(1):25-9. doi: 10.1016/j.pathol.2015.11.015. Epub 2015 Dec 14. Pathology. 2016. PMID: 27020205
-
The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.Breast Cancer Res. 2003;5(5):254-7. doi: 10.1186/bcr623. Epub 2003 Jul 29. Breast Cancer Res. 2003. PMID: 12927035 Free PMC article. Review.
-
Pathology of high-risk breast lesions and ductal carcinoma in situ.Radiol Clin North Am. 2004 Sep;42(5):821-30, v. doi: 10.1016/j.rcl.2004.03.013. Radiol Clin North Am. 2004. PMID: 15337418 Review.
Cited by
-
High-risk lesions of the breast: concurrent diagnostic tools and management recommendations.Insights Imaging. 2021 May 26;12(1):63. doi: 10.1186/s13244-021-01005-6. Insights Imaging. 2021. PMID: 34037876 Free PMC article. Review.
-
Atypical Ductal Hyperplasia at the Margin of Lumpectomy Performed for Early Stage Breast Cancer: Is there Enough Evidence to Formulate Guidelines?Int J Surg Oncol. 2012;2012:297832. doi: 10.1155/2012/297832. Epub 2012 Dec 4. Int J Surg Oncol. 2012. PMID: 23304477 Free PMC article.
-
The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.BMC Cancer. 2016 Aug 23;16(1):671. doi: 10.1186/s12885-016-2697-z. BMC Cancer. 2016. PMID: 27553211 Free PMC article.
-
Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia.Ann Surg Oncol. 2024 Oct;31(11):7550-7558. doi: 10.1245/s10434-024-15788-7. Epub 2024 Jul 21. Ann Surg Oncol. 2024. PMID: 39034366
-
First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).Breast Cancer Res Treat. 2016 Sep;159(2):203-13. doi: 10.1007/s10549-016-3935-4. Epub 2016 Aug 13. Breast Cancer Res Treat. 2016. PMID: 27522516 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical